8364 J . Org. Chem., Vol. 62, No. 24, 1997
Ogawa et al.
diselenide. Benzene was purified by distillation from sodium
(>8%)-lead alloy before use. 1H NMR spectra of CDCl3
solutions were recorded on a J EOL J NM-GSX-270 (270 MHz)
spectrometer. 13C NMR spectra of CDCl3 solutions were also
recorded on a J EOL J NM-GSX-270 (68 MHz) spectrometer.
Chemical shifts in the 1H NMR and 13C NMR spectra were
determined relative to Me4Si. IR spectra were recorded on a
Perkin-Elmer Model 1600 spectrometer. Mass spectra were
recorded on a J EOL J MS-DX303 apparatus. Purification of
products was performed by using MPLC with Merck 25-40
mm mesh silica gel (Art 9390) and preparative TLC with
Wakogel B-5F silica gel (or recycling preparative HPLC (J apan
Analytical Industry Co., Ltd. Model LC-908, J AIGEL-1H and
-2H (GPC), length 600 mm, i.d. 20 mm, eluent CHCl3)). High-
resolution mass spectra (HRMS) and combustion analyses
were performed in the Instrumental Analysis Center of the
Faculty of Engineering, Osaka University. Registry numbers
are provided by the author.
P a lla d iu m -Ca ta lyzed On e-P ot Ca r bon yla tive La cton i-
za tion : Gen er a l P r oced u r e (Ta ble 1, en tr y 1). To a 50
mL stainless steel autoclave equipped with a magnetic stirring
bar were placed diphenyl disulfide (1.0 mmol), 2-propyn-1-ol
(1a ) (1.0 mmol), tetrakis(triphenylphosphine)palladium (Pd-
(PPh3)4) (0.02 mmol), and benzene (1 mL). The apparatus was
charged with carbon monoxide at 60 atm, and the mixture was
heated at 100 °C for 50 h with magnetic stirring. The resulting
brown precipitate was removed by filtration through Celite,
and the filtrate was concentrated under reduced pressure. The
crude mixture was analyzed by using a 1H and 13C NMR
spectrometer and then was separated by MPLC (silica gel, 25-
40 mm, length 310 mm, i.d. 25 mm, n-hexane/ether as eluent)
followed by HPLC to provide 83 mg of 3-(phenylthio)-2-buten-
4-olide (6a ) (43%, CA Registry No. 57061-30-0).15
4-Meth yl-3-(p h en ylselen o)-2-bu ten -4-olid e (7b) (Ta ble
1, en tr y 7): yellow oil; 1H NMR (270 MHz, CDCl3) δ 1.51 (d,
J ) 6.8 Hz, 3 H), 5.10 (q, J ) 6.8 Hz, 1 H), 5.48 (s, 1 H), 7.39-
7.48 (m, 3 H), 7.62-7.65 (m, 2 H); 13C NMR (68 MHz, CDCl3)
δ 20.23, 80.72, 115.70, 124.49, 130.11, 130.22, 135.91, 170.84;
IR (NaCl) 3057, 2982, 2929, 1746, 1571, 1163, 1056, 931, 743,
692 cm-1; mass spectrum (EI) m/z 254 (M+, 100). Anal. Calcd
for C11H10O2Se: C, 52.19; H, 3.98. Found: C, 52.23; H, 4.02.
4, 4-Dim eth yl-3-(ph en ylth io)-2-bu ten -4-olide (6c) (Table
1, en tr y 8): CA Registry No. 84246-67-3.17 13C NMR (68 MHz,
CDCl3) δ 26.62, 86.30, 109.66, 128.02, 130.14, 130.46, 134.60,
170.02, 177.98; mass spectrum (EI) m/z 220 (M+, 100).
1,3-Bis(p h en ylt h io)-4-m et h yl-4-h yd r oxy-2-p en t en -1-
on e ((Z)-4c): mp 103-104 °C (yellow solid); 1H NMR (270
MHz, CDCl3) δ 1.53 (s, 6 H), 2.27 (s, 1 H), 6.91 (s, 1 H), 7.09-
7.36 (m, 10 H) (NOE experiment: Irradiation of methyl singlet
at δ 1.53 resulted in a 23% enhancement at δ 6.91 (vinyl
singlet)); 13C NMR (68 MHz, CDCl3) δ 29.19, 75.20, 125.56,
126.87, 127.67, 128.96, 129.04, 129.22, 130.10, 134.38, 134.90,
157.41, 186.57; IR (KBr) 3496, 2979, 1672, 1585, 1479, 1440,
1037, 762, 746, 689 cm-1
. Anal. Calcd for C18H18O2S2: C,
65.42; H, 5.49; S, 19.40. Found: C, 65.05; H, 5.32; S, 19.32.
4,4-Dim et h yl-3-(p h en ylselen o)-2-b u t en -4-olid e (7c)
(Ta ble 1, en tr y 9): oil; 1H NMR (270 MHz, CDCl3) δ 1.57 (s,
6 H), 5.29 (s, 1 H), 7.41-7.47 (m, 3 H), 7.61-7.64 (m, 2 H);
13C NMR (68 MHz, CDCl3) δ 26.89, 87.52, 114.46, 124.59,
130.06, 130.17, 135.98, 169.87, 176.02; IR (NaCl) 3058, 2980,
1749, 1573, 1240, 1117, 980, 923, 812, 835, 744, 691 cm-1; mass
spectra (CI), m/z 269 (M+ + 1, 100). Anal. Calcd for C12H12O2-
Se: C, 53.94; H, 4.53. Found: C, 53.76; H, 4.70.
4-(P h en ylth io)-1-oxaspir o[4.4]-3-n on en -2-on e (6d) (Table
1, en tr y 10): mp 59-61 °C (a white solid); 1H NMR (270 MHz,
CDCl3) δ 1.79-2.38 (m, 8 H), 5.16 (s, 1 H), 7.46-7.57 (m, 5
H); 13C NMR (68 MHz, CDCl3) δ 25.15, 38.66, 96.36, 110.66,
128.12, 130.20, 130.40, 134.77, 170.31, 175.44; IR (KBr) 2966,
1754, 1572, 1472, 1440, 1270, 1148, 938, 832, 762, 598, 586
cm-1; mass spectrum (EI) m/z 246 (M+, 61). Anal. Calcd for
C14H14O2S: C, 68.27; H, 5.73; S, 13.02. Found: C, 68.33, H,
5.69; S, 12.96.
1,3-Bis(ph en ylth io)-3-(1′-h ydr oxycyclopen tyl)-2-pr opan -
1-on e (4d ): mp 87-88 °C (a light yellow solid); 1H NMR (270
MHz, CDCl3) δ 1.62-1.95 (m, 6 H), 2.04 (s, 1 H), 2.07-2.14
(m, 2 H), 6.96 (s, 1 H), 7.10-7.35 (m, 10 H); 13C NMR (68 MHz,
CDCl3) δ 24.16, 39.97, 85.80, 125.97, 126.81, 127.68, 128.95,
129.02, 129.18, 129.93, 134.36, 135.06, 155.81, 186.49; IR (KBr)
3489, 3055, 2949, 1669, 1582, 1478, 1440, 1043, 1008, 754, 702,
579, 487 cm-1; mass spectrum (EI), m/z 247 (M+ - 109, 67).
Anal. Calcd for C20H20O2S2; C, 67.38; H, 5.65; S 17.99.
Found: C, 67.67; H, 5.68; S, 17.93.
The following compounds were prepared according to the
general procedure. The reaction listed in Table 2 was also
carried out under similar reaction conditions. The structures
of lactones obtained were characterized unambiguously on the
basis of analytical and spectral data.
3-(P h en ylselen o)-2-bu ten -4-olid e (7a ) (Ta ble 1, en tr y
2): yellow oil; 1H NMR (270 MHz, CDCl3) δ 4.72 (s, 2 H), 5.76
(s, 1 H), 7.39-7.48 (m, 3 H), 7.63-7.66 (m, 2 H); 13C NMR (68
MHz, CDCl3) δ 73.51, 115.60, 123.32, 130.01, 130.10, 136.00,
164.50, 171.80; IR (NaCl) 3058, 2932, 1770, 1742, 1567, 1440,
1249, 1150, 1008, 884, 845, 744, 692 cm-1; mass spectra (EI)
m/z 240 (M+, 100). Anal. Calcd for C10H8O2Se: C, 50.23; H,
3.37. Found: C, 49.98; H, 3.41.
3-[(p-Meth ylph en yl)selen o]-2-bu ten -4-olide (7a ′) (Table
1
1, en tr y 4): yellow oil; H NMR (270 MHz, CDCl3) δ 2.39 (s,
3 H), 4.70 (d, J ) 1.7 Hz, 2 H), 5.75 (t, J ) 1.7 Hz, 1 H), 7.21
(d, J ) 7.9 Hz, 2 H), 7.51 (d, J ) 7.9 Hz, 2 H); 13C NMR (68
MHz, CDCl3) δ 21.22, 73.61, 115.46, 119.73, 130.88, 136.05,
140.62, 165.09, 172.00; IR (NaCl) 3024, 2924, 1774, 1743, 1569,
1490, 1249, 1149, 1007, 883, 846, 807, 725, 697 cm-1; mass
spectrum (EI) m/z 254 (M+, 100). Anal. Calcd for C11H10O2Se:
C, 52.19; H, 3.98. Found: C, 52.37; H, 4.08.
4-(P h en ylselen o)-1-oxa sp ir o[4.4]-3-n on en -2-on e (7d )
1
(Ta ble 1, en tr y 11): mp 85-89 °C (a white solid); H NMR
(270 MHz, CDCl3) δ 1.82-2.18 (m, 8 H), 5.33 (s, 1 H), 7.42-
7.50 (m, 3 H), 7.60-7.70 (m, 2 H); 13C NMR (68 MHz, CDCl3)
δ 25.09, 38.90, 97.61, 115.41, 124.67, 130.08, 130.22, 136.11,
170.14, 173.44; IR (KBr) 2966, 1736, 1564, 1442, 1246, 1149,
946, 922, 834, 752, 692, 578, 478 cm-1; mass spectrum (EI),
m/z 294 (M+, 70). Anal. Calcd for C14H14O2Se: C, 57.35; H,
4.81. Found: C, 57.18; H, 4.80.
3-[[(p -T r iflu o r o m e t h y l)p h e n y l]s e le n o ]-2-b u t e n -4-
olid e (7a ′) (Ta ble 1, en tr y 5): mp 48-49 °C (a white solid);
1H NMR (270 MHz, CDCl3) δ 4.78 (s, 2 H), 5.80 (s, 1 H), 7.69
(d, J ) 7.7 Hz, 2 H), 7.82 (d, J ) 7.7 Hz, 2 H); 13C NMR (68
MHz, CDCl3) δ 73.52, 116.61, 123.43 (q, J ) 273 Hz), 126.89
(q, J ) 3.8 Hz), 128.06, 132.30 (q, J ) 33 Hz), 136.31, 162.71,
171.45; IR (KBr) 3067, 2970, 1783, 1736, 1571, 1249, 1166,
1124, 1006, 834, 702, 596, 500, 438 cm-1; mass spectrum (EI)
m/z 308 (M+, 100). Anal. Calcd for C11H7O2F3Se: C, 43.02; H,
2.30. Found: C, 43.24; H, 2.43.
4-(P h en ylselen o)-1-oxa sp ir o[5.4]-3-d eca n -2-on e (7e)
(Ta ble 1, en tr y 12): mp 101-106 °C (a white solid); 1H NMR
(270 MHz, CDCl3) δ 1.65-2.05 (m, 10 H), 5.28 (s, 1 H), 7.35-
7.51 (m, 3 H), 7.61-7.64 (m, 2 H); 13C NMR (68 MHz, CDCl3)
δ 22.06, 24.46, 36.21, 89.27, 114.36, 124.73, 130.08, 130.22,
136.11, 170.36, 176.22; IR (KBr) 3044, 2932, 1740, 1568, 1269,
1251, 1211, 931, 888, 835, 754, 694, 578, 478 cm-1; mass
spectrum (EI), m/z 308 (M+, 100). Anal. Calcd for C15H16O2-
Se: C, 58.64; H, 5.25. Found: C, 54.43; H, 5.36.
3-(P h en ylt h io)-2-p en t en -5-olid e (6f) (Ta b le 1, en t r y
13): mp 71-73 °C (a yellow solid); 1H NMR (270 MHz, CDCl3)
δ 2.59 (t, J ) 6.1 Hz, 2 H), 4.39 (t, J ) 6.1 Hz, 2 H), 5.32 (s, 1
H), 7.46-7.52 (m, 5 H); 13C NMR (68 MHz, CDCl3) δ 28.67,
65.68, 110.15, 127.03, 130.03, 130.49, 135.37, 161.06, 163.18;
IR (KBr) 3056, 2893, 1708, 1591, 1472, 1398, 1290, 1210, 1202,
4-Meth yl-3-(p h en ylth io)-2-bu ten -4-olid e (6b) (Ta ble 1,
en tr y 6): CA Registry No. 75717-37-2.16 13C NMR (68 MHz,
CDCl3) δ 20.00, 79.20, 110.75, 127.86, 130.15, 130.48, 134.48,
170.95, 173.73; mass spectrum (EI), m/z 206 (M+, 100).
(15) (a) Andre`s, D. F.; Dietrich, U.; Laurent, E. G.; Marquet, B. S.
Tetrahedron 1997, 53, 647. (b) Hollingworth, G. J .; Perkins, G.;
Sweeney, J . J . Chem. Soc., Perkin Trans. 1 1996, 1913. (c) Townsend,
C. A.; Christensen, S. B.; Davis, S. G. J . Chem. Soc., Perkin Trans. 1
1988, 839.
(16) (a) Xiao, W.-J .; Alper, H. J . Org. Chem. 1997, 62, 3422. (b)
Bakuzis, P.; Bakuzis, M. L. F. J . Org. Chem. 1981, 46, 235.
(17) Barbier, P.; Benezra, C. Tetrahedron Lett. 1982, 23, 3511.